The characteristics of profibrosis markers and endothelial dysfunctions in asthma patientswith obesity and diabetes mellitus type 2

Authors

DOI:

https://doi.org/10.15587/2519-4798.2018.148972

Keywords:

asthma, diabetes mellitus type 2, obesity, cytokines, profibrotic markers, endothelial dysfunction

Abstract

The urgency of asthma (A) and comorbid pathologies such as diabetes mellitus type 2 (DM2) and obesity is doubtless in internal medicine.

The aim. To study the effects of profibrotic mediators, endothelial dysfunction markers and homeostasis on the pulmonary and renal functions in patients with moderately severe and uncontrolled A.

Materials and methods.The study involved 252 patients with: A – group І (n=62), A+DM2– group ІІ(n=105), A+obesity– group ІІІ(n=85). General clinical methods of examination were combined with assessments of the respiratory unction, loop flow volume, fasting blood glucose level, insulin level, НОМА-IR,МСР-1, ІL-8, ММР-9, endothelin-1(ЕТ-1), von Willebrand factor (VWF) and glomerular filtration rate (GFR).

Results. Group II had the longest duration of the illness and the state of carbohydrate metabolism subcompensation. FEV1 in the groups: I = 64.0 [44.5;69.3] %, II = 51.0 [44.2;78.0] %, ІІІ = 57.0 [44.5;69.3] %; group III had the highest BMI. Groups II developed hyper glycaemia, II and III groups higher HOMA-IR and ET-1 concentration. All groups showed differently strong positive relationships between HOMA-IR and MCP-1. In group II, an excessive concentration of MCP-1 as the marker of fibrosis with progressing signs of a renal involvement was restrained by a proportional increase of fibrolysis indicator MMP-9 in favour of adaptive responses. A negative correlation with GFR and a positive one with albuminuria confirmed engagement of MCP-1 into tubulointerstitial damage processes. VWF was elevated in all patients and increasing with augmentation and severity of the course of A with comorbid states and involvement of vascular endothelium.

Conclusions. A patients with comorbid states developed higher levels, versus isolated A and the controls, of MCP-1, ІL-8 and MMP-9 in blood, therewith revealing the participation of these molecular mediators in affection of the lungs and kidneys by the universal mechanism of formation of fibroplastic changes in the respiratory tract and tubulointerstitial fibrosis

Author Biographies

Galyna Yeryomenko, Kharkiv National Medical University Nauky ave., 4, Kharkiv, Ukraine, 61022

PhD, Associate Professor

Department of Propedeutic of Internal Medicine No. 2 and Nursing Care

Tetyana Ospanova, Kharkiv National Medical University Nauky ave., 4, Kharkiv, Ukraine, 61022

MD, Professor

Department of Propedeutic of Internal Medicine No. 2 and Nursing Care

Tetyana Bezditko, Kharkiv National Medical University Nauky ave., 4, Kharkiv, Ukraine, 61022

MD, Professor

Department of Propedeutic of Internal Medicine No. 2 and Nursing Care

References

  1. Delyagin, V. M., Arakcheyeva, E. E., Urazbagambetov, A., Budchanov, Yu. I. (2012). Genetika bronkhial'noy astmy i atopii [Genetics of bronchial asthma and atopy]. Medical Council, 5, 33–39.
  2. Global Initiative for Asthma (GINA) (2017). Available at: www.ginasthma.org
  3. Feshchenko, Y. I. (2016). Bronkhialna astma u sviti ta v Ukraini: yak pokrashchyty yii kontrol? [Asthma around the world and in Ukraine: how to improve its control?]. Health of Ukraine, 3 (35), 11.
  4. Radchenko, O. M., Slaba, O. R. (2014). Fenotyp bronkhialnoi astmy z ozhyrinniam [Phenotype of bronchial asthma with obesity]. Asthma and Allergy, 2, 19–21.
  5. Nathan, D. M., Davidson, M. B., DeFronzo, R. A., Heine, R. J., Henry, R. R., Pratley, R., Zinman, B. (2007). Impaired Fasting Glucose and Impaired Glucose Tolerance: Implications for care. Diabetes Care, 30 (3), 753–759. doi: http://doi.org/10.2337/dc07-9920
  6. Basha, B., Samuel, S. M., Triggle, C. R., Ding, H. (2012). Endothelial Dysfunction in Diabetes Mellitus: Possible Involvement of Endoplasmic Reticulum Stress? Experimental Diabetes Research, 2012, 1–14. doi: http://doi.org/10.1155/2012/481840
  7. Kutyrina, I. M., Rudenko, T. E., Savelyeva, S. A., Shvetsov, M. Y., Shestakova, M. V. (2013). Kardiorenal'nyi sindrom u bol'nykh khronicheskoy bolezn'yu pochek i sakharnym diabetom [Cardiorenal syndrome in patients with chronic kidney disease and diabetes mellitus]. Diabetes Mellitus, 3 (60), 90–96.
  8. Narizhna, A. V. (2015). Fibrotychni pokaznyky (MSR-1, MMR-9) u khvorykh z dysfunktsiieiu nyrok na tli KhSN ta tsukrovoho diabetu 2-ho typu zalezhno vid rivnia shvydkosti klubochkovoi filtratsii [Fibrotic parameters (MCP-1, MMP-9) in patients with kidney dysfunction on the background of CHF and type 2 diabetes, depending on the level of glomerular filtration rate]. Ukrainian Cardiology Journal. Kyiv, 172.
  9. Pertseva, T. A., Nudga, N. P. (2011). Astma i ozhirenie: kakova vzaimosvyaz'? [Asthma and obesity: what is the relationship?]. Ukranian Pulmonology Journal, 3, 61–64.
  10. Taylor, B., Mannino, D., Brown, C., Crocker, D., Twum-Baah, N., Holguin, F. (2008). Body mass index and asthma severity in the National Asthma Survey. Thorax, 63 (1), 14–20. doi: http://doi.org/10.1136/thx.2007.082784
  11. Kochemasova, Т. V. (2000). Sostoyanie endoteliya i adgeziya leykotsitov pri sakharnom diabete [Condition of endothelium and adhesion of leukocytes in diabetes mellitus]. Diabetes Mellitus, 3, 59–62.
  12. Biletskyi, S. V., Novytska, O. Z., Petrynych, O. A., Kazantseva, T. V. (2014). Stan vuhlevodnoho, lipidnoho obminu ta shvydkist klubochkovoi filtratsii u khvorykh na hipertonichnu khvorobu II stadii ta v poiednanni z tsukrovym diabetom typu 2 [The state of carbohydrate, lipid metabolism and glomerular filtration rate in patients with hypertension and stage and in combination with type 2 diabetes]. Bukovinian Medical Herald, 18, 2 (70), 8–10.
  13. Pinhasov, B. B., Leutov, Y. V., Deev, D. A., Selyatiatskaya, V. G. (2017). Stratifikatsiya riska razvitiya i tyazhesti metabolicheskogo sindroma u patsientov terapevticheskogo profilya [Stratification of risk of development and severity of metabolic syndrome in patients of therapeutic profile]. Clinical Medicine, 5, 412–418
  14. Mueller, N. T., Koh, W.-P., Odegaard, A. O., Gross, M. D., Yuan, J.-M., Pereira, M. A. (2013). Asthma and the risk of type 2 diabetes in the Singapore Chinese Health Study. Diabetes Research and Clinical Practice, 99 (2), 192–199. doi: http://doi.org/10.1016/j.diabres.2012.11.019
  15. Baffi, C. W., Winnica, D. E., Holguin, F. (2015). Asthma and obesity: mechanisms and clinical implications. Asthma Research and Practice, 1 (1). doi: http://doi.org/10.1186/s40733-015-0001-7
  16. Holguin, F., Bleecker, E. R., Busse, W. W., Calhoun, W. J., Castro, M., Erzurum, S. C. et. al. (2011). Obesity and asthma: An association modified by age of asthma onset. Journal of Allergy and Clinical Immunology, 127 (6), 1486–1493. doi: http://doi.org/10.1016/j.jaci.2011.03.036
  17. Agapitov, L. I., Belozerov, Yu. M., Misernitsky, Y. L. (2012). Endotelin-1 i faktor Villebranda v razvitii legochnoy gipertenzii u detey s khronicheskoy bronkholegochnoy patologiey [Endotelin-1 and Willebrand factor in the development of pulmonary hypertension in children with chronic bronchopulmonary pathology]. Clinical Laboratory Diagnostics, 1, 11–13.
  18. Levey, A. S., Inker, L. A., Coresh, J. (2014). GFR Estimation: From Physiology to Public Health. American Journal of Kidney Diseases, 63 (5), 820–834. doi: http://doi.org/10.1053/j.ajkd.2013.12.006
  19. Voronina, M. S., Shilkina, N. P., Vinogradov, A. A., Butusova, S. V. (2014). Interleykiny 4, 6, 8 v patogeneze revmatoidnogo artrita i ego oslozhneniy [Interleukins 4, 6,8 inthe pathogenesis of rheumatoid arthritis and its complications] Cytokines and inflammation, 13 (1), 5–10.
  20. Gereng, Y. N., Sukhodolo, I. V., Pleshko, R. I., Ogorodova, L. M., Bukreyeva, Y. B., Selivanova, P. A. et. al. (2009). Morfologicheskie markery remodelirovaniya slizistoy obolochki bronkhov pri tyazheloy forme bronkhial'noy astmy i khronicheskoy obstruktivnoy bolezni legkikh [Morphological markers of remodeling of the bronchial mucosa in the severe form of bronchial asthma and chronic obstructive pulmonary disease]. Pulmonology, 4, 35–39.
  21. Chen, J., Muntner, P., Hamm, L. L., Jones, D. W., Batuman, V., Fonseca, V. et. al. (2004). The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults. Annals of Internal Medicine, 140 (3), 167–174. doi: http://doi.org/10.7326/0003-4819-140-3-200402030-00007
  22. Polyakov, V. V., Senatorova, A. S. (2012). Klinicheskoe znachenie endotelial'noy disfunktsii u detey s retsidiviruyushhim obstruktivnym bronkhitom i bronkhial'noy astmoy [Clinical significance of endothelial dysfunction in children with relapsing obstructive bronchitis and bronchial asthma]. International Medical Journal, 2, 32–35.
  23. Spirina, M. M., Bednyakova, A. V., Voronina, L. P., Polunina, O. S., Sevostyanova, I. V. (2011). Analiz urovnya interleykina-8 pri bronkhial'noy astme [Analysis of the level of interleukin-8 at bronchial asthma]. Astrakhan Medical Journal, 6 (2), 139–142.
  24. Bondar, I. A., Klimontov, V. V., Parfenteva, E. M., Romanov, V. V., Nadeyev, A. P. (2011). Mochevaya ekskretsiya kollagena IV tipa – ranniy marker fibrozirovaniya pochek pri sakharnom diabete [Urinary excretion of type IV collagen as an early marker of renal fibrosis in patients with diabetes mellitus]. Diabetes mellitus, 4, 29–31.
  25. Voronina, L. P., Yatsenko, M. K., Trubnikov, G. A., Afanasyev, Y. A., Uklistaya, T. A., Polunina, O. S. (2004). Rol' endotelina-1 v razvitii khronicheskoy obstruktivnoy patologii legkikh [The role of endothelin-1 inthe development of chronic obstructive pulmonary pathology]. Fundamental research, 6, 45–46.

Downloads

Published

2018-12-03

How to Cite

Yeryomenko, G., Ospanova, T., & Bezditko, T. (2018). The characteristics of profibrosis markers and endothelial dysfunctions in asthma patientswith obesity and diabetes mellitus type 2. ScienceRise: Medical Science, (7 (27), 33–38. https://doi.org/10.15587/2519-4798.2018.148972

Issue

No. 7 (27) (2018)

Section

Medical Science

License

Copyright (c) 2018 Galyna Yeryomenko, Tetyana Ospanova, Tetyana Bezditko

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.

Authors, who are published in this journal, agree to the following conditions:

1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.

 2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.